$327 Million is the total value of Blue Water Life Science Advisors, LP's 13 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 250.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NTRA | Buy | NATERA INC | $67,444,000 | +9.4% | 722,181 | +30.5% | 20.63% | +2.8% |
| GH | Buy | GUARDANT HEALTH INC | $39,102,000 | +146.6% | 390,945 | +208.3% | 11.96% | +131.9% |
| AKYA | New | AKOYA BIOSCIENCES INC | $26,192,000 | – | 1,710,807 | +100.0% | 8.01% | – |
| AVTR | New | AVANTOR INC | $17,288,000 | – | 410,270 | +100.0% | 5.29% | – |
| DHR | New | DANAHER CORPORATION | $10,330,000 | – | 31,400 | +100.0% | 3.16% | – |
| New | PEAR THERAPEUTICS INC | $1,207,000 | – | 194,686 | +100.0% | 0.37% | – | |
| New | BETTER THERAPEUTICS INC | $465,000 | – | 100,000 | +100.0% | 0.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NATERA INC | 12 | Q3 2023 | 33.3% |
| GUARDANT HEALTH INC | 12 | Q3 2023 | 21.3% |
| AKOYA BIOSCIENCES INC | 8 | Q3 2023 | 23.4% |
| ADAPTIVE BIOTECHNOLOGIES COR | 8 | Q3 2023 | 17.7% |
| CAREDX INC | 7 | Q2 2022 | 19.0% |
| THERMO FISHER SCIENTIFIC INC | 5 | Q4 2021 | 16.0% |
| MAXCYTE INC | 5 | Q3 2023 | 11.8% |
| BIO-TECHNE CORP | 5 | Q3 2022 | 8.8% |
| SOMALOGIC INC | 5 | Q3 2022 | 3.8% |
| CYTEK BIOSCIENCES INC | 4 | Q1 2023 | 12.5% |
View Blue Water Life Science Advisors, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-18 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Blue Water Life Science Advisors, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.